Predict your next investment

LP Pharmaceuticals company logo
HEALTHCARE | Drug Delivery
lppharma.com

See what CB Insights has to offer

Founded Year

2012

Stage

Series C | Alive

Total Raised

$103.08M

Last Raised

$72.34M | 1 yr ago

About LP Pharmaceuticals

LP Pharmaceutical, located in Xiamen Biomedical Industry Base, formulates and manufactures pharmaceuticals with enhanced delivery properties. Proprietary delivery platforms include mucosal and oral controlled release. Therapeutic areas currently concern the central nervous system, digestive system, cardiovascular, cancer, and AIDS.

LP Pharmaceuticals Headquarter Location

120 XinYuan Rd Suite 401

Xiamen, Fujian, 361022,

China

0592 -6898505

Latest LP Pharmaceuticals News

Impact Of Covid-19 On Retinoblastoma Treatment Market Demand and Future Scope With Top Key Players- GlaxoSmithKline plc., Spectrum Pharmaceuticals, Inc., CryoConcepts LP and Others

Jun 23, 2021

Search jobs 23-Jun-2021 Impact Of Covid-19 On Retinoblastoma Treatment Market Demand and Future Scope With Top Key Players- GlaxoSmithKline plc., Spectrum Pharmaceuticals, Inc., CryoConcepts LP and Others Cancer is the leading cause of death worldwide with 8.2 million cancer related deaths in 2012 estimated by World Health Organization (WHO). Retinoblastoma is a cancer that starts in the retina, the very back part of the eye. It is the most common type of eye cancer in children. During the early stages of development, the eyes have cells called retinoblasts that divide into new cells and fill the retina. Impact of COVID-19 on the Healthcare Industry The COVID-19 pandemic has causedsevere impacts on the global economy at various levels and which can be seen onthe Healthcare industry as well. The thriving market of health care researchand development is expected to exhibit a steep decline in the sales during thelockdown period owing to the shutdown of the manufacturing units, acuteshortage in the supply of raw materials and absence of potential manpower. Itcan be deduced from the current situations brought about by the pandemic thatthe production, and supply chain activities have experienced minor hurdles.However, the market is projected to gradually recover post-COVID-19, which willpresent attractive opportunities for sales across various regions of the worldin the following years. Future Market Insights (FMI) adopteda multidisciplinary approach during the pandemic-era to focus on the growth anddevelopment of the RetinoblastomaTreatment Market . The study features insights on thecurrent growth dynamics and the major revenue reforms prevailing in the marketas along with the key takeaways over the forecast. The team of analysts at Future MarketInsights are focussing on research and market study to produce different RetinoblastomaTreatment Market forecasts and predictions at both national and internationallevels. They have considered several leads of information pertaining to theindustry like market figures and merger estimations to assess and producereliable and informative insights on the Retinoblastoma Treatment Market. To remain ‘ahead’ of your competitors, Ask aQuestion >> https://www.futuremarketinsights.com/ask-question/rep-gb-2783 Key Players The writer will create content on thegeneral strategies of market players. And then will write the key players inthe market are: Baxter, Bristol-Myers Squibb Company, GlaxoSmithKline plc.,Spectrum Pharmaceuticals, Inc., CryoConcepts LP and Others Segmentation The report provides insights on the important highlights and currenttrends prevailing in the market. This helps the readers to gain a deeperunderstanding and form an unbiased opinion on the market. Numeroussegmentations have been provided for this market based on: Based on the disease type, the globalretinoblastoma treatment market is segmented into the following: Congenital (Hereditary) Retinoblastoma Intraocular Retinoblastoma Surgery Hospitals Fullin-depth analysis of the parent market The analysts at FMI are dedicated toprovide insights after extensive research and study. The study also includesestimations, projections and evaluation of the market dynamics. Importantchanges in market dynamics The report has beencreated after detailed and exhaustive studies by the analysts at FMI taking severalfactors into consideration like monetary, ecological, social, mechanical, andpolitical status of a particular demography. They study the key data to assessthe revenue and production of manufacturers across various regions. Thereport also covers an in-depth analysis of the key changes in market dynamicsin the recent past and the near future. Segmentationdetails of the market Emerging segments and regional markets Queries Solved What are the key segments andsub-segments in the market? What are the key drivers, restraints,opportunities, and challenges of the Retinoblastoma Treatment Market in theHealthcare Industry, and how they are expected to impact the market? What are the attractive investmentopportunities within the Retinoblastoma Treatment Market in the HealthcareIndustry? What is the Retinoblastoma TreatmentMarket in the Healthcare Industry size at the regional and country-level? What are the key market playersfocusing on? What are the strategies for growthadopted by the key players in Retinoblastoma Treatment Market in the HealthcareIndustry? What are the recent trends in RetinoblastomaTreatment Market in the Healthcare Industry? (M&A, partnerships, newproduct developments, expansions)? What are the challenges to the RetinoblastomaTreatment Market in the growth of the Healthcare Industry? What are the key market trendsimpacting the growth of the Retinoblastoma Treatment Market in the HealthcareIndustry? To receive extensive list of importantregions, ask for TOC here >>  https://www.futuremarketinsights.com/toc/rep-gb-2783 Table of Content MarketBackground    Reasons to Buythe report We provide authentic and detailed ananalysis on various market trends to enable businesses to make informed andbeneficial decisions to attain competitive edge over key players. Our analysts provide detailed marketsegmentation along with meaningful insights and extensive reports that othercompanies fail to include. The report includes accurate analysisof the market and the current developing trends affecting the growth. FMI speaks tostakeholders across the spectrum, including C-level executives, distributors,product manufacturers, industry experts. This ensures that the data collected is fromhighly reliable sources. Explore Wide-ranging Coverage of FMI’s HealthcareLandscape Transradial Closure Devices Market – According to Future Market Insights (FMI), the demand from hospitals,independent catheterization centers, and healthcare clinics will continuerising. Spurred by this, the global transradial closure devices market is setto grow by 6.5% CAGR during the forecast period from the year 2020 to 2030. In Vitro FertilizationBanking Services Market – The in vitro fertilization banking services market,despite undergoing a temporary period of lull due to COVID-19 outbreak, islikely to have an impressive growth trajectory between 2020 and 2030. Cryopreservationfor In-vitro Fertilization (IVF) Market – According to analysis by Future Market Insights (FMI), cryopreservationfor IVF market surpassed a valuation of US$ 339 million in 2019. Themarket is set to reflect an impressive 10.2% CAGR through 2030. About FMI        Future Market Insights (FMI) is a leading provider of marketintelligence and consulting services, serving clients in over 150countries. FMI  isheadquartered in Dubai, the global financial capital, and has delivery centersin the U.S. and India. FMI’s latest  marketresearch reports  and industry analysis help businesses navigatechallenges and make critical decisions with confidence and clarity amidstbreakneck competition. Our customized and syndicated market research reportsdeliver actionable insights that drive sustainable growth. A team of expert-ledanalysts at FMI continuously tracks emerging trends and events in a broad rangeof industries to ensure that our clients prepare for the evolving needs oftheir consumers. ContactUs

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing LP Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

LP Pharmaceuticals is included in 5 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

N

Neuroscience

2,144 items

Companies developing products that monitor, analyze, protect, or otherwise influence the structure/function of the nervous system.

B

Biopharmaceuticals

5,732 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

C

Cancer

3,604 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

I

Infectious Disease

2,226 items

Entities aiding the surveillance, screening, prevention, diagnosis, treatment, and containment of infections & the maintenance of public wellbeing during outbreaks.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.